Ifebemtinib tosylate
Product Specifications
CAS Number
2761021-80-9
Target
FAK
Related Pathways
Cytoskeletal Signaling, Angiogenesis, Tyrosine Kinase/Adaptors
Bioactivity
Ifebemtinib (tosylate) (BI-853520 (tosylate) ; IN-10018 (tosylate) ) is a highly selective PTK2 kinase inhibitor with anti-tumor properties. It inhibits FAK autophosphorylation in prostate cancer cells and suppresses spheroid formation and in situ tumor growth in vivo. Ifebemtinib (tosylate) is applicable in cancer research, including studies on solid tumors, breast cancer, and malignant pleural mesothelioma.
Smiles
O=C(NC1CCN(C)CC1)C=2C=C(OC)C(=CC2F)NC3=NC=C(C(=N3)OC4=CC=CC5=C4C(=O)N(C)C5)C(F)(F)F.O=S(=O)(O)C1=CC=C(C=C1)C
Molecular Formula
C35H36F4N6O7S
Molecular Weight
760.76
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
